Machine learning methods to predict amyloid positivity using domain scores from cognitive tests
Abstract Amyloid- $$\beta$$ β (A $$\beta$$ β ) is the target in many clinical trials for Alzheimer’s disease (AD). Preclinical AD patients are heterogeneous with regards to different backgrounds and diagnosis. Accurately predicting A $$\beta$$ β status of participants by using machine learning (ML)...
Saved in:
Main Authors: | Guogen Shan, Charles Bernick, Jessica Z. K. Caldwell, Aaron Ritter |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/ea894322e2e844929f1099088cdfa50c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting amyloid positivity in patients with mild cognitive impairment using a radiomics approach
by: Jun Pyo Kim, et al.
Published: (2021) -
Prediction of Amyloid Positivity in Mild Cognitive Impairment Using Fully Automated Brain Segmentation Software
by: Kang KM, et al.
Published: (2020) -
Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
by: Pyun JM, et al.
Published: (2021) -
Z Scores, Standard Scores, and Composite Test Scores Explained
by: Chittaranjan Andrade
Published: (2021) -
Validation of 2006 WHO prediction scores for true HIV infection in children less than 18 months with a positive serological HIV test.
by: Cécile Alexandra Peltier, et al.
Published: (2009)